CBT reduces CBF: cognitive-behavioral therapy reduces cerebral blood flow in fear-relevant brain regions in spider phobia

Brain and Behavior

Volumn 6, Issue 9, 2016, Pages

  Soravia, Leila M ^a   Orosz, Ariane ^a   Schwab, Simon ^a   Nakataki, Masahito ^a,b   Wiest, Roland ^c   Federspiel, Andrea ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anticipatory anxiety; arterial spin labeling; cerebral blood flow; cognitive behavioral therapy; fear processing; phobia

Indexed keywords

ADULT; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE BEHAVIORAL THERAPY; FEMALE; FRONTAL EYE FIELD; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEAD INJURY; HUMAN; INSULA; MENTAL DISEASE; PARAHIPPOCAMPAL GYRUS; PARTICIPANT OBSERVATION; PHOBIA; PRIORITY JOURNAL; PSYCHOTHERAPY; SPIDER; STIMULUS; THALAMUS;

EID: 84988345882     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.510     Document Type: Article

References (50)

1. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, (DSM-5®). American Psychiatric Pub.
2. APA. 1994. Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, DC.
3. Bentz, D., T. Michael, D. J. F. de Quervain, and F. H. Wilhelm. 2010. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. J. Anxiety Disord. 24:223–230.
4. Blakemore, R. L., S. W. Rieger, and P. Vuilleumier. 2016. Negative emotions facilitate isometric force through activation of prefrontal cortex and periaqueductal gray. NeuroImage 124(Part A):627–640.
5. Brozovich, F. A., and R. G. Heimberg. 2013. Mental imagery and post-event processing in anticipation of a speech performance among socially anxious individuals. Behav. Ther. 44:701–716.
6. Cabeza, R., and L. Nyberg. 2000. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12:1–47.
7. Dai, W., D. Garcia, C. de Bazelaire, and D. C. Alsop. 2008. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn. Reson. Med. 60:1488–1497.
8. Del Casale, A., S. Ferracuti, C. Rapinesi, D. Serata, M. Piccirilli, V. Savoja, et al. 2012. Functional neuroimaging in specific phobia. Psychiatry Res. 202:181–197.
9. Duval, E. R., A. Javanbakht, and I. Liberzon. 2015. Neural circuits in anxiety and stress disorders: a focused review. Ther. Clin. Risk Manag. 11:115.
10. Essau, C., H. Wittchen, and H. Pfister. 1999. DIA-X-interview. Diagnostica 45:163–164.
11. Fehm, L., and J. Margraf. 2002. Thought suppression: specificity in agoraphobia versus broad impairment in social phobia? Behav. Res. Ther. 40:57–66.
12. Foa, E. B., and M. J. Kozak. 1986. Emotional processing of fear: exposure to corrective information. Psychol. Bull. 99:20–35.
13. Furmark, T., M. Tillfors, I. Marteinsdottir, H. Fischer, A. Pissiota, B. Langstrom, et al. 2002. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch. Gen. Psychiatry 59:425–433.
14. Hermans, D., M. G. Craske, S. Mineka, and P. F. Lovibond. 2006. Extinction in human fear conditioning. Biol. Psychiatry 60:361–368.
15. Johanson, A., J. Risberg, D. M. Tucker, and L. Gustafson. 2006. Changes in frontal lobe activity with cognitive therapy for spider phobia. Appl. Neuropsychol. 13:34–41.
16. Kircher, T., V. Arolt, A. Jansen, M. Pyka, I. Reinhardt, T. Kellermann, et al. 2013. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol. Psychiatry 73:93–101.
17. Klumpp, H., M. K. Keutmann, D. A. Fitzgerald, S. A. Shankman, and K. L. Phan. 2014. Resting state amygdala-prefrontal connectivity predicts symptom change after cognitive behavioral therapy in generalized social anxiety disorder. Biol. Mood Anxiety Disord. 4:1–7.
18. Lang, P., M. Bradley, and B. Cuthbert. 2008. International affective picture system (IAPS): affective ratings of pictures and instruction manual. Univ. of Florida, Gainesville, FL.
19. Laposa, J. M., K. C. Collimore, and N. A. Rector. 2014. Is post-event processing a social anxiety specific or transdiagnostic cognitive process in the anxiety spectrum? Behav. Cogn. Psychother. 42:706–717.
20. McNally, R. J. 2007. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders. Clin. Psychol. Rev. 27:750–759.
21. Moser, M. B., and E. I. Moser. 1998. Distributed encoding and retrieval of spatial memory in the hippocampus. J. Neurosci. 18:7535–7542.
22. Münsterkötter, A. L., S. Notzon, R. Redlich, D. Grotegerd, K. Dohm, V. Arolt, et al. 2015. Spider or no spider? Neural correlates of sustained and phasic fear in spider phobia. Depress. Anxiety 32:656–663.
23. Paquette, V., J. Lévesque, B. Mensour, J.-M. Leroux, G. Beaudoin, P. Bourgouin, et al. 2003. “Change the mind and you change the brain”: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. NeuroImage 18:401–409.
24. de Quervain, D. J., and J. Margraf. 2008. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur. J. Pharmacol. 583:365–371.
25. de Quervain, D. J., K. Henke, A. Aerni, V. Treyer, J. L. McGaugh, T. Berthold, et al. 2003. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur. J. Neurosci. 17:1296–1302.
26. de Quervain, D. J., A. Aerni, G. Schelling, and B. Roozendaal. 2009. Glucocorticoids and the regulation of memory in health and disease. Front. Neuroendocrinol. 30:358–370.
27. Rapee, R. M., and R. G. Heimberg. 1997. A cognitive-behavioral model of anxiety in social phobia. Behav. Res. Ther. 35:741–756.
28. Rickham, P. 1964. Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br. Med. J. 2:177.
29. Rinck, M., S. Bundschuh, S. Engler, A. Muller, J. Wissmann, T. Ellwart, et al. 2002. Reliability and validity of German versions of three instruments measuring fear of spiders. Diagnostica 48:141–149.
30. Rubio-Stipec, M., and M. Bravo. 1991. The Composite International Diagnostic Interview (CIDI): an epidemiologic instrument suitable for using in conjunction with different diagnostic systems in different cultures. Acta Psiquiatr. Psicol. Am. Lat. 37:191–204.
31. Sakamoto, H., R. Fukuda, T. Okuaki, M. Rogers, K. Kasai, T. Machida, et al. 2005. Parahippocampal activation evoked by masked traumatic images in posttraumatic stress disorder: a functional MRI study. NeuroImage 26:813–821.
32. Schienle, A., A. Schäfer, B. Walter, R. Stark, and D. Vaitl. 2005. Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neurosci. Lett. 388:1–6.
33. Schienle, A., A. Schäfer, A. Hermann, S. Rohrmann, and D. Vaitl. 2007. Symptom provocation and reduction in patients suffering from spider phobia. Eur. Arch. Psychiatry Clin. Neurosci. 257:486–493.
34. Schienle, A., A. Schäfer, R. Stark, and D. Vaitl. 2009. Long-term effects of cognitive behavior therapy on brain activation in spider phobia. Psychiatry Res. 172:99–102.
35. Simmons, A., I. Strigo, S. C. Matthews, M. P. Paulus, and M. B. Stein. 2006. Anticipation of aversive visual stimuli is associated with increased insula activation in anxiety-prone subjects. Biol. Psychiatry 60:402–409.
36. Soravia, L. M., M. Heinrichs, L. Winzeler, M. Fisler, W. Schmitt, H. Horn, et al. 2014. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia. Depress. Anxiety 31:429–435.
37. Spielberger, C. D., R. C. Gorsuch, and R. E. Lushene. 1970. Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, CA.
38. Squire, L. R. 1992. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99:195–231.
39. Straube, T., M. Glauer, S. Dilger, H.-J. Mentzel, and W. H. Miltner. 2006. Effects of cognitive-behavioral therapy on brain activation in specific phobia. NeuroImage 29:125–135.
40. Straube, T., H.-J. Mentzel, and W. H. Miltner. 2007. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. NeuroImage 37:1427–1436.
41. Suzuki, H., M. Misaki, F. Krueger, and J. Bodurka. 2015. Neural responses to truth telling and risk propensity under asymmetric information. PLoS One 10:e0137014.
42. Szymanski, J., and W. O'Donohue. 1995. Fear of spider questionnaire. J. Behav. Ther. Exp. Psychiatry 26:31–34.
43. Volz, K. G., R. I. Schubotz, and D. Y. von Cramon. 2003. Predicting events of varying probability: uncertainty investigated by fMRI. NeuroImage 19:271–280.
44. Volz, K. G., R. I. Schubotz, and D. Y. von Cramon. 2004. Why am I unsure? Internal and external attributions of uncertainty dissociated by fMRI. NeuroImage 21:848–857.
45. Vuilleumier, P., J. L. Armony, J. Driver, and R. J. Dolan. 2001. Effects of attention and emotion on face processing in the human brain: an event-related fMRI study. Neuron 30:829–841.
46. Wang, J., G. K. Aguirre, D. Y. Kimberg, A. C. Roc, L. Li, and J. A. Detre. 2003. Arterial spin labeling perfusion fMRI with very low task frequency. Magn. Reson. Med. 49:796–802.
47. Wendt, J., M. Lotze, A. I. Weike, N. Hosten, and A. O. Hamm. 2008. Brain activation and defensive response mobilization during sustained exposure to phobia-related and other affective pictures in spider phobia. Psychophysiology 45:205–215.
48. Wittchen, H. U., and H. Pfister. 1997. Instruktionsmanual zur durchführung von DIA-X-interviews. Swets Test Services, Frankfurt.
49. Wu, W. C., M. Fernandez-Seara, J. A. Detre, F. W. Wehrli, and J. Wang. 2007. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn. Reson. Med. 58:1020–1027.
50. Zeidan, F., K. T. Martucci, R. A. Kraft, J. G. McHaffie, and R. C. Coghill. 2014. Neural correlates of mindfulness meditation-related anxiety relief. Soc. Cogn. Affect. Neurosci. 9:751–759.